3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
2
Stomatitis
2
Squamous Cell Carcinoma of Head and Neck
2
Mouth Neoplasms
2
Leukemia, Myeloid, Acute
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Ureteral Neoplasms
1
Tonsillar Neoplasms
1
Tongue Neoplasms
1
Rectal Neoplasms
1
Parotid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Oligometastatic Malignant Solid Neoplasm
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Maxillary Sinus Neoplasms
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Carcinoma
1
Interventions
Gemcitabine
6
Specimen Handling
4
Cisplatin
4
pembrolizumab
3
enfortumab vedotin
3
atezolizumab
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Carboplatin
3
vinflunine
2
eribulin
2
avelumab
2
Standard of Care
2
Biopsy
2
vandetanib
1
tocilizumab
1
tamibarotene
1
rucaparib
1
relatlimab
1
pegfilgrastim
1
merphos
1
guadecitabine
1
genexol-PM
1
dehydroftorafur
1
carotuximab
1
Vitamin D
1
Vinblastine
1
Ramucirumab
1
Radiotherapy
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Ureteral Neoplasms
×
Practice Guidelines as Topic
×
Clear all
NCT07087860
2026-05-08
RECIPE-B1
Mayo Clinic
Phase 2
Recruiting
70 enrolled